About Histopathology Department
Clinical Trials at Histopathology Department
During the past decade, Histopathology Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Histopathology Department"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Histopathology Department
According to Clinical.Site data, the most researched conditions in "Histopathology Department" are
"Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Histopathology Department" in a lesser frequency.
Clinical Trials Intervention Types at Histopathology Department
Most popular intervention types in "Histopathology Department" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Placebo (for enzalutamide)" (1 trials) and "exemestane" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Histopathology Department
The vast majority of trials in "Histopathology Department" are
2 trials for "Female" genders.
Clinical Trials Status at Histopathology Department
Currently, there are NaN active trials in "Histopathology Department".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Histopathology Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Histopathology Department, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".